About this trial
Enteral nutrition intolerance, manifested in delayed gastric emptying and high gastric residual, is a common problem in critically ill patients in intensive care, with adverse consequences on patients' outcomes. A decrease in the levels of the ghrelin hormone in these patients may contribute to this problem. The gastric residual test (GRV) is used to assess enteral absorption and gastric motility, but the traditional methods can lead to inaccuracy and waste of resources. In recent years, the use of ultrasound (PoCUS) to assess GRV has developed, but its effect on the rate of reaching the caloric goal has not yet been evaluated.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Pregnant patient 2. History of bariatric or other gastric surgery 3. Post-operative patients with sub-costal incision 4. Diaphragmatic hernia 5. Patients who recieve parenteral nutrition 6. Technically difficult US exam
Trial design
Parallel
Treatments tested in this trial
Ultrasound assessment
Diagnostic testUltrasound assessment of gastric residual volume
Treatment groups
Trial outcomes
Primary outcomes
Reaching the daily caloric goal
To compare the daily caloric goal via gastric residual volume assessment with ultrasound vs. gastric aspiration
Sponsors and contacts
Click on the lead sponsor to view all of their trials.